Patent Application for Zero-TSNA Technology

Star Scientific, through its CEO, Jonnie R. Williams, has filed a new US patent application for technology to produce zero-nitrosamine tobacco. According to a report on its website (http://www.starscientific.com), Star has made the application for a 'novel modification of its patented curing technology that results in the production of tobacco leaf that consistently contains levels of carcinogenic TSNAs (known as NNNs and NNKs) that are below detection even by the most sensitive measures'. Star made the announcement of the patent application in conjunction with its wholly-owned subsidiary, Rock Creek Pharmaceuticals, as part of their 'continuing efforts to lessen the harm linked with tobacco use'. Enditem